List of bibliographic references
Number of relevant bibliographic references: 21.
[0-20] [
0 - 20][
0 - 21][
20-20][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000006 (2002) |
Joanne E. Nash ; Jonathan M. Brotchie | Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat |
| 000051 (2001) |
Susan H. Fox ; Brian Henry ; Micheal P. Hill ; David Peggs ; Alan R. Crossman ; Jonathan M. Brotchie | Neural mechanisms underlying peak‐dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan |
| 000059 (2010) |
Tom H. Johnston ; Anne Van Der Meij ; Jonathan M. Brotchie ; Susan H. Fox | Effect of histamine H2 receptor antagonism on levodopa–induced dyskinesia in the MPTP‐macaque model of Parkinson's disease |
| 000115 (2005) |
Jonathan M. Brotchie | Nondopaminergic mechanisms in levodopa‐induced dyskinesia |
| 000120 (2006) |
Susan H. Fox ; Anthony E. Lang ; Jonathan M. Brotchie | Translation of nondopaminergic treatments for levodopa‐induced dyskinesia from MPTP‐lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure |
| 000148 (2010) |
Philippe Huot ; Tom H. Johnston ; Tayyeba Darr ; Lili-Naz Hazrati ; Naomi P. Visanji ; Donna Pires ; Jonathan M. Brotchie ; Susan H. Fox | Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations |
| 000228 (2011) |
James B. Koprich ; Susan H. Fox ; Tom H. Johnston ; Allan Goodman ; Bertrand Le Bourdonnec ; Roland E. Dolle ; Robert N. Dehaven ; Diane L. Dehaven-Hudkins ; Patrick J. Little ; Jonathan M. Brotchie | The selective mu‐opioid receptor antagonist adl5510 reduces levodopa‐induced dyskinesia without affecting antiparkinsonian action in mptp‐lesioned macaque model of Parkinson's disease |
| 000249 (2003) |
Gregorio Segovia ; Francisco Mora ; Alan R. Crossman ; Jonathan M. Brotchie | Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high‐dose levodopa in the reserpine‐treated rat model of Parkinson's disease |
| 000473 (2003) |
Juha-Matti Savola ; Michael Hill ; Mia Engstrom ; Hannele Merivuori ; Siegfried Wurster ; Steven G. Mcguire ; Susan H. Fox ; Alan R. Crossman ; Jonathan M. Brotchie | Fipamezole (JP‐1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease |
| 000642 (2007) |
Giovanni Fabbrini ; Jonathan M. Brotchie ; Francisco Grandas ; Masahiro Nomoto ; Christopher G. Goetz | Levodopa‐induced dyskinesias |
| 000764 (2006) |
Jordi Gomez-Ramirez ; Tom H. Johnston ; Naomi P. Visanji ; Susan H. Fox ; Jonathan M. Brotchie | Histamine H3 receptor agonists reduce L‐dopa–induced chorea, but not dystonia, in the MPTP‐lesioned nonhuman primate model of Parkinson's disease |
| 000779 (2006) |
Naomi P. Visanji ; Jordi Gomez-Ramirez ; Tom H. Johnston ; Donna Pires ; Valerie Voon ; Jonathan M. Brotchie ; Susan H. Fox | Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease |
| 000782 (2010) |
Tom H. Johnston ; Susan H. Fox ; Matthew J. Piggott ; Juha-Matti Savola ; Jonathan M. Brotchie | The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates |
| 000A14 (1999) |
Brian Henry ; Susan H. Fox ; David Peggs ; Alan R. Crossman ; Jonathan M. Brotchie | The α2‐adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti‐parkinsonian actions of L‐dopa in the MPTP‐lesioned primate model of Parkinson's disease |
| 000E67 (2009) |
Susan H. Fox ; Rosalind Chuang ; Jonathan M. Brotchie | Serotonin and Parkinson's disease: On movement, mood, and madness |
| 001416 (2008) |
Naomi P. Visanji ; Rob M. A. De Bie ; Tom H. Johnston ; Andrew C. Mccreary ; Jonathan M. Brotchie ; Susan H. Fox | The nociceptin/orphanin FQ (NOP) receptor antagonist J‐113397 enhances the effects of levodopa in the MPTP‐lesioned nonhuman primate model of Parkinson's disease |
| 002708 (2006) |
Michael P. Hill ; Paula Ravenscroft ; Steven G. Mcguire ; Jonathan M. Brotchie ; Alan R. Crossman ; Catherine Rochat ; Mark J. Millan | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 002870 (1991) |
Jonathan M. Brotchie ; Mitchell ; Michael A. Sambrook ; Alan R. Crossman | Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate |
| 002967 (2000) |
Susan H. Fox ; Jonathan M. Brotchie | 5‐HT2C receptor binding is increased in the substantia nigra pars reticulata in Parkinson's disease |
| 002C59 (2003) |
Michael P. Hill ; Erwan Bezard ; Steven G. Mcguire ; Alan R. Crossman ; Jonathan M. Brotchie ; Ann Michel ; Renee Grimée ; Henrik Klitgaard | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset |
| 003166 (2002) |
Susan H. Fox ; Mark Kellett ; A. Peter Moore ; Alan R. Crossman ; Jonathan M. Brotchie | Randomised, double‐blind, placebo‐controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i -k "Jonathan M. Brotchie"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i \
-Sk "Jonathan M. Brotchie" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= indexItem
|index= Author.i
|clé= Jonathan M. Brotchie
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
